Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM574 and motilin in dogs

Japanese Journal of Pharmacology

Volumn 71, Issue 1, 1996, Pages 29-38

  Inatomi, Nobuhiro ^a   Sato, Fumihiko ^a   Marui, Shogo ^a   Itoh, Zen ^b   Omura, Satoshi ^c  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Cholinergic neuron; Cisapride; EM574; Enteric nervous system; Motilin

Indexed keywords

8,9 ANHYDRO N ISOPROPYLNORERYTHROMYCIN A 6,9 HEMIACETAL; ATROPINE; CISAPRIDE; ERYTHROMYCIN DERIVATIVE; HEXAMETHONIUM; MOTILIN; ONDANSETRON; SEROTONIN 3 RECEPTOR; TETRAGASTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; FORCE TRANSDUCER; GASTROINTESTINAL MOTILITY; INTESTINE INNERVATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; STOMACH MOTILITY; STOMACH SECRETION; SUBCUTANEOUS DRUG ADMINISTRATION; UPPER GASTROINTESTINAL TRACT; VAGUS NERVE;

EID: 0029943930     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.29     Document Type: Article

References (36)

1. Itoh Z, Takeuchi S, Mori K, Taminato T, Seino Y, Imura H and Yanaihara N: Changes in plasma motilin concentration and gastrointestinal contractile activity in conscious dog. Am J Dig Dis 23, 929-935 (1978)
2. Itoh Z, Suzuki T, Nakaya M, Inoue M and Mitsuhashi S: Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. Antimicrob Agents Chemother 26, 863-869 (1984)
3. Itoh Z, Nakaya M, Suzuki T, Arai H and Wakabayashi K: Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 247, G688-G694 (1984)
4. Tomomasa T, Kuroume T, Arai H, Wakabayashi K and Itoh Z: Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 31, 157-161 (1986)
5. Tsuzuki K, Sunazuka T, Marui S, Toyoda H, Ōmura S, Inatomi N and Itoh Z: Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-Substituted and tertiary N-substituted derivatives of 8,9-anhydro-erythromycin A 6,9-hemiacetal. Chem Pharm Bull (Tokyo) 37, 2687-2700 (1989)
6. Satoh M, Sakai T, Sano I, Fujikura K, Koyama H, Ohshima K, Itoh Z and Ōmura S: EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. J Pharmacol Exp Ther 271, 574-579 (1994)
7. Inatomi N, Satoh H, Maki Y, Hashimoto N, Itoh Z and Ōmura S: An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs. J Pharmacol Exp Ther 251, 707-712 (1989)
8. 2α in conscious dogs. Jpn J Pharmacol 63, 209-217 (1993)
9. Ohtawa M, Mizumoto A, Hayashi N, Yanagida K, Itoh Z and Ōmura S: Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs. Gastroenterology 104, 1320-1327 (1993)
10. Holle GE, Steinbach E and Forth W: Effects of erythromycin in the dog upper gastrointestinal tract. Am J Physiol 263, G52-G59 (1992)
11. Fiorucci S, Bosso R and Morelli A: Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways. Dig Dis Sci 37, 1678-1684 (1992)
12. Wiseman LR and Faulds D: Cisapride, an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47, 116-152 (1994)
13. Hall KE, El-Sharkawy TY and Diamant NE: Vagal control of migrating motor complex in the dog. Am J Physiol 243, G276-G284 (1982)
14. Tomomasa T, Kuroume T, Arai H, Wakabayashi K and Itoh Z: Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 31, 157-161 (1986)
15. Sarna SK, Soergel KH, Koch TR, Stone JE, Wood CM, Ryan RP, Arndorfer RC, Cavanaugh JH, Nellans HN and Lee MB: Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 101, 1488-1496 (1991)
16. Tack J, Janssens J, Vantrappen G, Peeters T, Annese V, Depoortere I, Muls E and Bouillon R: Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 103, 72-79 (1992)
17. Varannes SBD, Parys V, Ropert A, Chayvialle JA, Roze C and Galmiche JP: Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 109, 32-39 (1995)
18. Kawamura O, Sekiguchi T, Kusano M, Nishioka T and Itoh Z: Effect of erythromycin on interdigestive gastrointestinal contractile activity and plasma motilin concentration in humans. Dig Dis Sci 38, 870-876 (1993)
19. Kawamura O, Sekiguchi T, Itoh Z and Ōmura S: Effect of erythromycin derivative EM523L on human interdigestive gastrointestinal tract. Dig Dis Sci 38, 1026-1031 (1993)
20. Depoortere I, Peeters T and Vantrappen G: The erythromycin derivative EM-523 is a potent motilin agonist in man and in rabbit. Peptides 11, 515-519 (1990)
21. Hasler WL, Heldsinger A and Owyang C: Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors. Am J Physiol 262, G50-G55 (1992)
22. 3 recognition sites in the ferret area postrema. J Pharm Pharmacol 40, 586-588 (1988)
23. 3 receptors in rat brain using radioligand binding. Nature 330, 746-748 (1987)
24. 3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159, 157-164 (1989)
25. Buchheit KH, Engel G, Mutschler E and Richardson B: Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol 329, 36-41 (1985)
26. Sanger GJ and Nelson DR: Selective and functional 5-hydroxytryptamine 3 receptor antagonism by BRL43694 (granisetron). Eur J Pharmacol 159, 113-124 (1989)
27. 3 receptors. Br J Pharmacol 94, 397-412 (1988)
28. Irland SJ and Tyers MB: Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90, 229-238 (1987)
29. Itoh Z, Mizumoto A, Iwanaga Y, Yoshida N, Torii K and Wakabayashi K: Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog. Gastroenterology 100, 901-908 (1991)
30. Buelbring E and Gershon MD: 5-Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach. J Physiol (Lond) 192, 823-846 (1967)
31. Andrews PLR: Vagal afferent innervation of the gastrointestinal tract. Prog Brain Res 61, 65-86 (1986)
32. Paintal AS: Vagal afferent fibers. Ergeb Physiol Biol Chem 52, 74-156 (1963)
33. Eisenberg MM, Emas GS and Grossman MI: Comparison of the effect of 2-deoxy-D-glucose and insulin on gastric acid secretion in dogs. Surgery 60, 111-117 (1966)
34. Hirschowitz BI and Sachs G: Vagal gastric secretory stimulation by 2-deoxy-D-glucose. Am J Physiol 209, 452-460 (1965)
35. Koch H, Domschke S, Belonhlavek D, Domschke W, Wünsch E, Jaeger E and Demling L: Gastric mucosal blood flow and pepsin secretion in dogs - Stimulation by 13-Nle-motilin. Scand J Gastroenterol 11, 93-96 (1976)
36. Konturek SJ, Dembinski A, Krol R and Wünsch E: Effect of 13-Nle-motilin on gastric secretion, serum gastrin level and mucosal blood flow in dogs. J Physiol (Lond) 264, 665-672 (1977)